Published in Ann Med on January 01, 2003
Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model (2007) 0.98
Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One (2012) 0.94
Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions. Arterioscler Thromb Vasc Biol (2011) 0.87
Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models. BMC Cardiovasc Disord (2005) 0.78
A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury. Sci Rep (2016) 0.75
SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention. Oncotarget (2017) 0.75
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation (2006) 5.58
Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab (2010) 2.33
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res (2004) 2.31
Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol (2009) 2.26
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med (2004) 1.92
Cathepsin cysteine proteases in cardiovascular disease. FASEB J (2007) 1.92
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood (2010) 1.86
Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis (2012) 1.79
Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol (2002) 1.69
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation (2004) 1.69
Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. Eur Heart J (2013) 1.67
A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.63
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging (2009) 1.61
NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem (2008) 1.50
Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res (2009) 1.49
Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol (2006) 1.46
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2002) 1.45
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ Res (2004) 1.39
Angiotensin-converting enzyme and vascular remodeling. Circ Res (2007) 1.36
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med (2004) 1.34
The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood (2008) 1.29
Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood (2007) 1.27
Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res (2006) 1.21
Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res (2009) 1.20
Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol (2011) 1.19
Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Arterioscler Thromb Vasc Biol (2009) 1.18
In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging (2004) 1.14
The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res (2002) 1.14
Early atherosclerosis exhibits an enhanced procoagulant state. Circulation (2010) 1.14
Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. Radiology (2005) 1.14
Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol (2008) 1.12
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc Imaging (2009) 1.12
CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med (2002) 1.11
Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation (2005) 1.11
Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol (2007) 1.10
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost (2009) 1.09
Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol (2003) 1.08
Novel insights into pathological changes in muscular arteries of radiotherapy patients. Radiother Oncol (2009) 1.08
Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J Cereb Blood Flow Metab (2013) 1.06
Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation. Radiology (2012) 1.05
Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol (2007) 1.03
Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(-/-) mice. Int J Radiat Oncol Biol Phys (2008) 1.03
Biomechanical factors as triggers of vascular growth. Cardiovasc Res (2013) 1.01
Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J (2005) 1.01
Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol (2004) 1.01
Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol (2011) 0.99
Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion. Exp Physiol (2005) 0.98
Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response. FASEB J (2011) 0.94
Local heart irradiation of ApoE(-/-) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother Oncol (2012) 0.93
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol (2010) 0.93
E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res (2008) 0.93
Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol (2005) 0.93
Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Arterioscler Thromb Vasc Biol (2012) 0.91
Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J (2012) 0.91
Hypoxia in atherosclerosis and inflammation. Curr Opin Lipidol (2013) 0.91
Defective intercellular adhesion complex in myocardium predisposes to infarct rupture in humans. J Am Coll Cardiol (2008) 0.91
Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis (2005) 0.90
Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-of-concept study. Invest Radiol (2010) 0.90
In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans. JACC Cardiovasc Imaging (2015) 0.90
Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. Circ Res (2003) 0.89
Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc Pathol (2008) 0.88
Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism. J Am Coll Cardiol (2004) 0.88
Increased arterial expression of a glycosylated haptoglobin isoform after balloon dilation. Cardiovasc Res (2003) 0.88
Comparison of single-sequence T1w TFE MRI with multisequence MRI for the quantification of lipid-rich necrotic core in atherosclerotic plaque. J Magn Reson Imaging (2008) 0.88
Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine. Radiology (2009) 0.87
Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels. Thromb Haemost (2010) 0.87
Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice. PLoS One (2010) 0.87
Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: Initial results. J Magn Reson Imaging (2008) 0.86